ARD is an international peer-reviewed journal covering all aspects of rheumatology, including musculoskeletal conditions, arthritic disease and connective tissue disorders. ARD publishes basic, rheum arthritis journal, and translational scientific research, including the most important recommendations for the management of various conditions.
Switching from the bio-originators to biosimilar: is it premature to recommend this procedure? The most successful journal in the field of rheumatology, the present and the future. Annals of the Rheumatic Diseases, as he takes over as the editor-in-chief. ARD, the official journal of EULAR, covers all aspects of rheumatology from the spectrum of musculoskeletal conditions to arthritic disease and connective tissue disorders. The journal publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer-reviewed proceedings of international meetings are featured.
The Author Information section provides general guidelines and requirements for specific article types. Information is also provided on editorial policies and optional open access and colour fees. All manuscripts should be submitted online. Published by the BMJ Publishing Group Limited. This work was undertaken to develop new classification criteria for RA. Methods A joint working group from the ACR and the European League Against Rheumatism developed, in three phases, a new approach to classifying RA. A joint working group from the ACR and the European League Against Rheumatism developed, in three phases, a new approach to classifying RA.